Svіtlana Zahorodnia

6PUBLICATIONS
9CO-AUTHORS
Biologically active moleculesEpigenetics (incl. genome methylation and epigenomics)Biomolecular modelling and designMicro- and nanosystemsInorganic green chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 07, 2026
Ketodarolutamide may interact with the receptor-binding domain of the SARS-CoV-2 spike glycoprotein: the importance of halogenated benzonitrile.

|Apr 03, 2023
In silico study of HASDI (high-affinity selective DNA intercalator) as a new agent capable of highly selective recognition of the DNA sequence.

Andrii A Zaremba, Polina Yu Zaremba, Svitlana D Zahorodnia

|Nov 01, 2022
De novo designed inhibitor has high affinity to four variants of the RBD of S-glycoprotein of SARS-CoV-2 - an in silico study.

Andrii Zaremba, Polina Zaremba, Svіtlana Zahorodnia

|Oct 18, 2022
Effect of Coated Silver Nanoparticles on Cancerous vs. Healthy Cells.

Liubov Artiukh, Olga Povnitsa, Svitlana Zahorodnia

|Jun 24, 2022
Structure-Morphology-Antimicrobial and Antiviral Activity Relationship in Silver-Containing Nanocomposites Based on Polylactide.

Valeriy Demchenko, Yevgen Mamunya, Serhii Kobylinskyi

|Nov 08, 2018
Anti-Adenoviral Activity of 2-(3-Chlorotetrahydrofuran-2-yl)-4-Tosyl-5-(Perfluoropropyl)-1,2,3-Triazole.

Liubov Biliavska, Yuliia Pankivska, Olga Povnitsa

Pageof 1

Frequent Collaborators

3 joint publications

Andrii Zaremba

3 joint publications

Polina Zaremba

2 joint publications

Liubov Biliavska

2 joint publications

Olga Povnitsa